🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
10.73
-0.41 (-3.68%)
At close: Nov 18, 2026, 4:00 PM EST
10.79
+0.06 (0.56%)
After-hours: Nov 18, 2026, 5:27 PM EST

NovoCure Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, NovoCure stock has a consensus rating of "Buy" and an average price target of $26.14. The average 1-year stock price forecast is 143.62% higher than the current stock price, while the lowest is $15 (+39.79%) and the highest is $52 (+384.62%).

Price Target: $26.14 (+143.62%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$15$26.14$20$52
Change+39.79%+143.62%+86.39%+384.62%

Analyst Ratings

The average analyst rating for NovoCure stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy433333
Buy111111
Hold233333
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Maintains
$27 → $31
BuyMaintains$27 → $31+188.91%Nov 10, 2026
Unknown Analyst
Wells Fargo
No rating
Wells Fargo
Hold
Reiterates
$15
HoldReiterates$15+39.79%Nov 10, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$23 → $20
BuyMaintains$23 → $20+86.39%Oct 30, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$29
BuyReiterates$29+170.27%Oct 26, 2026
Wedbush
Wedbush
Hold
Maintains
$18 → $20
HoldMaintains$18 → $20+86.39%Jul 24, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
740.20M
from 655.35M
Increased by 12.95%
Revenue Next Year
809.26M
from 740.20M
Increased by 9.33%
EPS This Year
-1.05
from -1.22
EPS Next Year
-0.73
from -1.05
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
535.03M537.84M509.34M605.22M655.35M740.20M
Revenue Growth
8.23%0.53%-5.30%18.83%8.28%12.95%
Gross Profit
420.79M423.58M381.80M469.05M490.18M572.66M
Gross Margin
78.65%78.76%74.96%77.50%74.80%77.37%
Operating Income
-43.69M-88.91M-226.16M-167.54M-148.29M-102.91M
Net Income
-58.35M-92.53M-207.04M-168.63M-136.23M-122.00M
EPS
-----1.22-1.05
Free Cash Flow
-----75.68M-24.60M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High742.3M
Avg740.2M
Low737.1M

Revenue Growth

Revenue Growth202620272028
High
13.3%
Avg
12.9%
Low
12.5%

EPS Forecast

EPS202620272028
High-1.03
Avg-1.05
Low-1.09

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-